{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:15:48Z","timestamp":1790745348247,"version":"4.1.0"},"reference-count":250,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bcp.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,10,9]],"date-time":"2016-10-09T14:17:39Z","timestamp":1476022659000},"page":"4-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":242,"special_numbering":"C","title":["History of antimicrobial drug discovery: Major classes and health impact"],"prefix":"10.1016","volume":"133","author":[{"given":"Rustam","family":"Aminov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2016.10.001_b0005","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/146837a0","article-title":"An enzyme from bacteria able to destroy penicillin","volume":"146","author":"Abraham","year":"1940","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2016.10.001_b0010","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1046\/j.1469-0691.2000.00128.x","article-title":"Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making","volume":"6","author":"Acar","year":"2000","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b0015","first-page":"52","article-title":"Nonclassical biological activities of quinolone derivatives","volume":"15","author":"Ahmed","year":"2012","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b0020","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0149-2918(01)80028-X","article-title":"Quinupristin\/dalfopristin: a therapeutic review","volume":"23","author":"Allington","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bcp.2016.10.001_b0025","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1574-6968.2007.00757.x","article-title":"Evolution and ecology of antibiotic resistance genes","volume":"271","author":"Aminov","year":"2007","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.bcp.2016.10.001_b0030","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1111\/j.1462-2920.2009.01972.x","article-title":"The role of antibiotics and antibiotic resistance in nature","volume":"11","author":"Aminov","year":"2009","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.bcp.2016.10.001_b0035","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fmicb.2010.00134","article-title":"A brief history of the antibiotic era: lessons learned and challenges for the future","volume":"1","author":"Aminov","year":"2010","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2016.10.001_b0040","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fmicb.2011.00158","article-title":"Horizontal gene exchange in environmental microbiota","volume":"2","author":"Aminov","year":"2011","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2016.10.001_b0045","series-title":"Horizontal Gene Transfer in Microorganisms","isbn-type":"print","article-title":"The extent and regulation of lateral gene transfer in natural microbial ecosystems","author":"Aminov","year":"2012","ISBN":"https:\/\/id.crossref.org\/isbn\/9781908230102"},{"key":"10.1016\/j.bcp.2016.10.001_b0050","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fmicb.2013.00241","article-title":"Biotic acts of antibiotics","volume":"4","author":"Aminov","year":"2013","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bcp.2016.10.001_b0055","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fmicb.2013.00192","article-title":"Evolution in action: dissemination of tet(X) into pathogenic microbiota","volume":"4","author":"Aminov","year":"2013","journal-title":"Front. Microbiol."},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2016.10.001_b0060","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0924-8579(01)00410-1","article-title":"Advanced-generation macrolides: tissue-directed antibiotics","volume":"18","author":"Amsden","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"5707","key":"10.1016\/j.bcp.2016.10.001_b0065","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0070","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrmicro2761","article-title":"The rise of the Enterococcus: beyond vancomycin resistance","volume":"10","author":"Arias","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bcp.2016.10.001_b0075","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1126\/science.163.3864.255","article-title":"Disease in ancient Nubia","volume":"163","author":"Armelagos","year":"1969","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b0080","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jama.281.1.61","article-title":"Trends in infectious disease mortality in the United States during the 20th century","volume":"281","author":"Armstrong","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b0085","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0163-4453(96)80003-X","article-title":"Mechanisms of glycopeptide resistance in enterococci","volume":"32","author":"Arthur","year":"1996","journal-title":"J. Infect."},{"key":"10.1016\/j.bcp.2016.10.001_b0090","unstructured":"Bacitracin. 2010. Available at: http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=529."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2016.10.001_b0095","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0167-5877(96)01119-1","article-title":"Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms","volume":"31","author":"Bager","year":"1997","journal-title":"Prev. Vet. Med."},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0100","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1099\/ijs.0.02901-0","article-title":"Reclassification of Amycolatopsis mediterranei DSM 46095 as Amycolatopsis rifamycinica sp. nov.","volume":"54","author":"Bala","year":"2004","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"10.1016\/j.bcp.2016.10.001_b0105","series-title":"The Battle Against Bacteria: A Fresh Look","author":"Baldry","year":"1976"},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0110","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF00412210","article-title":"Metabolic products of microorganisms. 72. Naphthomycin, an antimetabolite of vitamin K","volume":"65","author":"Balerna","year":"1969","journal-title":"Arch. Mikrobiol."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0115","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cbpa.2009.02.031","article-title":"Daptomycin: mechanisms of action and resistance, and biosynthetic engineering","volume":"13","author":"Baltz","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2016.10.001_b0120","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7164\/antibiotics.31.170","article-title":"Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. II. Extraction and chemical characterization","volume":"31","author":"Bardone","year":"1978","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bcp.2016.10.001_b0125","first-page":"9","article-title":"Virginiamycin, a new antibiotic for growing swine","volume":"19","author":"Barnhart","year":"1960","journal-title":"J. Anim. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2016.10.001_b0130","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1128\/AAC.00678-12","article-title":"Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components","volume":"56","author":"Barnhill","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b0135","first-page":"566","article-title":"Antituberculosis Drugs","author":"Bartmann","year":"2013"},{"key":"10.1016\/j.bcp.2016.10.001_b0140","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.7001623","article-title":"Tetracycline-labelled human bone from ancient Sudanese Nubia (A.D. 350)","volume":"209","author":"Bassett","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.bcp.2016.10.001_b0145","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666160715115025","article-title":"Quinolones in the search for new anticancer agents","author":"Batalha","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2016.10.001_b0150","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/183257b0","article-title":"Synthesis of penicillin: 6-aminopenicillanic acid in penicillin fermentations","volume":"183","author":"Batchelor","year":"1959","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2016.10.001_b0155","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/jac\/dku572","article-title":"Antibiotics: the changing regulatory and pharmaceutical industry paradigm","volume":"70","author":"Bax","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.bcp.2016.10.001_b0160","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ijc.20010","article-title":"Geldanamycin, an inhibitor of the chaperone activity of HSP90, induces MAPK-independent cell cycle arrest","volume":"109","author":"Bedin","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.bcp.2016.10.001_b0165","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1128\/AAC.36.8.1744","article-title":"Teicoplanin metabolism in humans","volume":"36","author":"Bernareggi","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.bcp.2016.10.001_b0170","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1128\/AAC.00840-10","article-title":"Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptors","volume":"54","author":"Bertrand","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0175","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/antibiotics3040572","article-title":"Old and new glycopeptide antibiotics: action and resistance","volume":"3","author":"Binda","year":"2014","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0180","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1021\/jm00298a007","article-title":"Lincomycin. XI. Synthesis and structure of clindamycin, a potent antibacterial agent","volume":"13","author":"Birkenmeyer","year":"1970","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2016.10.001_b0185","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11274-016-2026-3","article-title":"Fate of virginiamycin through the fuel ethanol production process","volume":"32","author":"Bischoff","year":"2016","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.bcp.2016.10.001_b0190","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1517\/14728222.7.3.311","article-title":"Vancomycin resistance: occurrence, mechanisms and strategies to combat it","volume":"7","author":"Boneca","year":"2003","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bcp.2016.10.001_b0195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bcp.2016.10.001_b0200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mib.2015.05.008","article-title":"Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution","volume":"27","author":"Bollenbach","year":"2015","journal-title":"Curr. Opin. Microbiol."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1381612802666220921173820","article-title":"Oxazolidinone antibacterial agents","volume":"2","author":"Brickner","year":"1996","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2016.10.001_b0210","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/BF00638597","article-title":"Pikromycin, ein neues Antibiotikum aus Actinomycetes","volume":"37","author":"Brockmann","year":"1950","journal-title":"Naturwissenschaften"},{"key":"10.1016\/j.bcp.2016.10.001_b0215","first-page":"184","article-title":"Pikromycin, ein bitter schmeckendes Antibioticum aus Actinomyceten","volume":"84","author":"Brockmann","year":"1951","journal-title":"Antibiotica aus Actinomyceten"},{"issue":"3","key":"10.1016\/j.bcp.2016.10.001_b0220","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1179\/1973947815Y.0000000068","article-title":"Antimicrobials therapy of anaerobic infections","volume":"28","author":"Brook","year":"2016","journal-title":"J. Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b0225","series-title":"Chapter 46. Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","first-page":"2021","article-title":"Protein synthesis inhibitors and miscellaneous antibacterial agents","author":"Brunton","year":"2005"},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0230","first-page":"404","article-title":"Vincenzo Tiberio: a misunderstood researcher","volume":"8","author":"Bucci","year":"2011","journal-title":"Ital. J. Public Health"},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0235","first-page":"321","article-title":"The arseno-therapy of syphilis; stovarsol, and tryparsamide","volume":"1","author":"Burke","year":"1925","journal-title":"Br. J. Vener. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0240","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/(SICI)1097-0282(1999)51:2<129::AID-BIP3>3.0.CO;2-Y","article-title":"Gramicidin D conformation, dynamics and membrane ion transport","volume":"51","author":"Burkhart","year":"1999","journal-title":"Biopolymers"},{"key":"10.1016\/j.bcp.2016.10.001_b0245","series-title":"Cold Spring Harb. Perspect. Med.","first-page":"a025247","article-title":"\u03b2-Lactams and \u03b2-lactamase inhibitors: an overview","author":"Bush","year":"2016"},{"key":"10.1016\/j.bcp.2016.10.001_b0250","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.3382\/ps.2007-00249","article-title":"History of the use of antibiotic as growth promoters in European poultry feeds","volume":"86","author":"Castanon","year":"2007","journal-title":"Poult. Sci."},{"key":"10.1016\/j.bcp.2016.10.001_b0255","unstructured":"CDC, Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available at: http:\/\/www. cdc.gov\/drugresistance\/pdf\/ar-threats-2013-508.pdf."},{"key":"10.1016\/j.bcp.2016.10.001_b0260","doi-asserted-by":"publisher","first-page":"14917","DOI":"10.1074\/jbc.M400666200","article-title":"A novel \u03b2-lactamase activity from a penicillin-binding protein of Treponema pallidum and why syphilis is still treatable with penicillin","volume":"279","author":"Cha","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2016.10.001_b0265","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/01.blo.0000183429.83168.07","article-title":"THE CLASSIC: penicillin as a chemotherapeutic agent. 1940","volume":"439","author":"Chain","year":"2005","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"14","key":"10.1016\/j.bcp.2016.10.001_b0270","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1056\/NEJMoa025025","article-title":"Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene","volume":"348","author":"Chang","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.bcp.2016.10.001_b0275","first-page":"1283","article-title":"Streptogramin, a new antibiotic","volume":"3","author":"Charney","year":"1953","journal-title":"Antibiot. Chemother. (Northfield)"},{"key":"10.1016\/j.bcp.2016.10.001_b0280","unstructured":"Chatham House Report, 2015. Towards a New Global Business Model for Antibiotics: Delinking Revenues from Sales. Edited by C. Clift, U. Gopinathan, C. Morel, K. Outterson, J.-A. R\u00f8ttingen, A. So. Available at: https:\/\/www.chathamhouse.org\/sites\/files\/chathamhouse\/field\/field_document\/20151009NewBusinessModelAntibioticsCliftGopinathanMorelOuttersonRottingenSo.pdf."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0285","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0290","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/MMBR.43.2.145-192.1979","article-title":"Antibiotics of the virginiamycin family, inhibitors which contain synergistic components","volume":"43","author":"Cocito","year":"1979","journal-title":"Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2016.10.001_b0295","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5694\/j.1326-5377.1999.tb123568.x","article-title":"Vancomycin-resistant enterococci and use of avoparcin in animal feed: is there a link?","volume":"171","author":"Collignon","year":"1999","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.bcp.2016.10.001_b0300","series-title":"Drug Discovery Practices, Processes, and Perspectives","author":"Corey","year":"2013"},{"issue":"9995","key":"10.1016\/j.bcp.2016.10.001_b0305","first-page":"743","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Collaborators","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2016.10.001_b0310","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ajpa.1330800202","article-title":"Fluorochrome labelling in Roman period skeletons from Dakhleh Oasis, Egypt","volume":"80","author":"Cook","year":"1989","journal-title":"Am. J. Phys. Anthropol."},{"issue":"9","key":"10.1016\/j.bcp.2016.10.001_b0315","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1021\/ja0572912","article-title":"Total synthesis and evaluation of [Psi[CH2NH]Tpg4]vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding","volume":"128","author":"Crowley","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bcp.2016.10.001_b0320","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1592\/phco.20.19.1469.34858","article-title":"Quinupristin-dalfopristin: an overview","volume":"20","author":"Delgado","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.bcp.2016.10.001_b0325","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/jac\/dkf045","article-title":"Echinocandins: a new class of antifungal","volume":"49","author":"Denning","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.bcp.2016.10.001_b0330","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/ng.3548","article-title":"Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance","volume":"48","author":"Desjardins","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2016.10.001_b0335","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/jac\/24.4.485","article-title":"The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes","volume":"4","author":"Di Giambattista","year":"1989","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0340","article-title":"Chloramphenicol derivatives as antibacterial and anticancer agents: historic problems and current solutions","volume":"5","author":"Dinos","year":"2016","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.bcp.2016.10.001_b0345","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1055\/s-0028-1129486","article-title":"Ein Beitrag zur Chemotherapie der bakteriellen Infektionen","volume":"61","author":"Domagk","year":"1935","journal-title":"Deutsch. Med. Wschr."},{"key":"10.1016\/j.bcp.2016.10.001_b0350","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1039\/b803796p","article-title":"Quorum sensing by 2-alkyl-4-quinolones in Pseudomonas aeruginosa and other bacterial species","volume":"4","author":"Dubern","year":"2008","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.bcp.2016.10.001_b0355","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1749-6632.1948.tb27262.x","article-title":"Aureomycin: a product of the continuing search for new antibiotics","volume":"51","author":"Duggar","year":"1948","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcp.2016.10.001_b0360","series-title":"Die Experimentelle Chemotherapie der Spirilosen","author":"Ehrlich","year":"1910"},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0365","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/jac\/dku530","article-title":"Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials","volume":"70","author":"Eliakim-Raz","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b0370","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1086\/367662","article-title":"Quinupristin-dalfopristin and linezolid: evidence and opinion","volume":"36","author":"Eliopoulos","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bcp.2016.10.001_b0375","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/jac\/dkh217","article-title":"Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure","volume":"53","author":"Enne","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b0380","unstructured":"EPC, Ban on Antibiotics as Growth Promoters in Animal Feed Enters into Effect, European Commission \u2013 IP\/05\/1687, 2005. Available at: http:\/\/europa.eu\/rapid\/press-release_IP-05-1687_en.htm."},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b0385","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/tcrm.2007.3.1.71","article-title":"Comparison of echinocandin antifungals","volume":"3","author":"Eschenauer","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"issue":"9","key":"10.1016\/j.bcp.2016.10.001_b0390","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.bcp.2016.10.001_b0395","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1586\/14787210.6.5.593","article-title":"Potential of old-generation antibiotics to address current need for new antibiotics","volume":"6","author":"Falagas","year":"2008","journal-title":"Expert Rev. Anti-infective Ther."},{"key":"10.1016\/j.bcp.2016.10.001_b0400","unstructured":"FDA, Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals. Department of Health and Human Services, 2009. Available at: www.fda.gov\/downloads\/ForIndustry\/UserFees\/AnimalDrugUserFeeActADUFA\/UCM231851.pdf."},{"key":"10.1016\/j.bcp.2016.10.001_b0405","unstructured":"FDA, FDA News Release, 2012. Available at: (http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm333695.htm)."},{"key":"10.1016\/j.bcp.2016.10.001_b0410","unstructured":"FDA, FDA approves Sivextro to treat skin infections, 2014. Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm402174.htm."},{"key":"10.1016\/j.bcp.2016.10.001_b0415","unstructured":"FDA, FDA Announces Pending Withdrawal of Approval of Nitarsone, 2015. Available at: www.fda.gov\/AnimalVeterinary\/NewsEvents\/CVMUpdates\/ucm440668.htm."},{"key":"10.1016\/j.bcp.2016.10.001_b0420","unstructured":"FDA, Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals, 2015. Available at: https:\/\/docs.google.com\/viewer?url=http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FForIndustry%2FUserFees%2FAnimalDrugUserFeeActADUFA%2FUCM440584.pdf."},{"key":"10.1016\/j.bcp.2016.10.001_b0425","unstructured":"FDA, Fluoroquinolone Antibacterial Drugs: Drug Safety Communication \u2013 FDA Advises Restricting Use for Certain Uncomplicated Infections, 2016. Available at: http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm500665.htm."},{"key":"10.1016\/j.bcp.2016.10.001_b0430","first-page":"226","article-title":"On antibacterial action of culture of penicillium, with special reference to their use in isolation of B. influenzae","volume":"10","author":"Fleming","year":"1929","journal-title":"Br. J. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0435","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1021\/cr030112j","article-title":"Rifamycin-mode of action, resistance, and biosynthesis","volume":"105","author":"Floss","year":"2005","journal-title":"Chem. Rev."},{"issue":"Suppl. 2","key":"10.1016\/j.bcp.2016.10.001_b0440","first-page":"ii45","article-title":"Safety and tolerability of linezolid","volume":"51","author":"French","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.bcp.2016.10.001_b0445","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1128\/AAC.00039-06","article-title":"Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus","volume":"50","author":"Friedman","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.bcp.2016.10.001_b0450","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2016.10.001_b0455","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"3918","key":"10.1016\/j.bcp.2016.10.001_b0460","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/154703a0","article-title":"Gramicidin S and its use in the Treatment of Infected Wounds","volume":"154","author":"Gause","year":"1944","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2016.10.001_b0465","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/MCP.0b013e32834daff8","article-title":"Macrolides in the treatment of asthma","volume":"18","author":"Good","year":"2012","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.bcp.2016.10.001_b0470","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0140-6736(05)70799-6","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study","volume":"365","author":"Goossens","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2016.10.001_b0475","series-title":"Antimicrobial Drugs: Chronicle of a Twentieth Century Medical Triumph","first-page":"464","author":"Greenwood","year":"2008"},{"key":"10.1016\/j.bcp.2016.10.001_b0480","series-title":"Vital Statistics Rates in the United States, 1940-1960","first-page":"1968","author":"Groves","year":"1968"},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0485","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0924-8579(98)00050-8","article-title":"Clinical relevance of a European collaborative study on comparative susceptibility of Gram-positive clinical isolates to teicoplanin and vancomycin","volume":"10","author":"Gr\u00fcneberg","year":"1998","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"48","key":"10.1016\/j.bcp.2016.10.001_b0490","doi-asserted-by":"publisher","first-page":"19097","DOI":"10.1073\/pnas.0707340104","article-title":"A gene family encoding the major toxins of lethal Amanita mushrooms","volume":"104","author":"Hallen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0495","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1128\/MMBR.37.2.166-196.1973","article-title":"Chemistry and biology of the polyene macrolide antibiotics","volume":"37","author":"Hamilton-Miller","year":"1973","journal-title":"Bacteriol. Rev."},{"issue":"6","key":"10.1016\/j.bcp.2016.10.001_b0500","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/jac\/27.6.702","article-title":"From foreign pharmacopoeias: \u2018new\u2019 antibiotics from old?","volume":"27","author":"Hamilton-Miller","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b0505","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defence peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcp.2016.10.001_b0510","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1741-7007-2-4","article-title":"Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin","volume":"2","author":"Harms","year":"2004","journal-title":"BMC Biol."},{"key":"10.1016\/j.bcp.2016.10.001_b0515","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0021-9258(17)41580-8","article-title":"Antibiotic substances produced by Pseudomonas aeruginosa","volume":"159","author":"Hays","year":"1945","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0520","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1574-6976.2010.00247.x","article-title":"Quinolones: from antibiotics to autoinducers","volume":"35","author":"Heeb","year":"2011","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bcp.2016.10.001_b0525","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1126\/science.1110699","article-title":"A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA","volume":"308","author":"Hegde","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bcp.2016.10.001_b0530","doi-asserted-by":"publisher","first-page":"34780","DOI":"10.1074\/jbc.M001608200","article-title":"DNA gyrase-mediated wrapping of the DNA strand is required for the replication fork arrest by the DNA gyrase-quinolone-DNA ternary complex","volume":"275","author":"Hiasa","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.bcp.2016.10.001_b0535","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1056\/NEJMc1212055","article-title":"U.S. outpatient antibiotic prescribing, 2010","volume":"368","author":"Hicks","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b0540","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"issue":"22","key":"10.1016\/j.bcp.2016.10.001_b0545","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1021\/ja01118a001","article-title":"The structure of terramycin","volume":"75","author":"Hochstein","year":"1953","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0550","first-page":"355","article-title":"Tetracycline-labeled human bone from a medieval population in Nubia\u2019s Batn El Hajar (550\u20131450 A.D.)","volume":"54","author":"Hummert","year":"1982","journal-title":"Hum. Biol."},{"issue":"42","key":"10.1016\/j.bcp.2016.10.001_b0555","doi-asserted-by":"publisher","first-page":"12512","DOI":"10.1002\/chem.201001279","article-title":"Antibacterials from the sea","volume":"16","author":"Hughes","year":"2010","journal-title":"Chemistry"},{"key":"10.1016\/j.bcp.2016.10.001_b0560","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.bmc.2010.10.061","article-title":"Novel 9a,11-bridged azalides: One-pot synthesis of N\u2032-substituted 2-imino-1,3-oxazolidines condensed to an azalide aglycone","volume":"19","author":"I\u0161tuk","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2016.10.001_b0565","doi-asserted-by":"publisher","unstructured":"IUPAC, Compendium of Chemical Terminology, 2nd ed. (the \u201cGold Book\u201d). Compiled by A.D. McNaught, A. Wilkinson. Blackwell Scientific Publications, Oxford (1997). XML on-line corrected version: http:\/\/goldbook.iupac.org (2006-) created by M. Nic, J. Jirat, B. Kosata; updates compiled by A. Jenkins. ISBN 0-9678550-9-8. doi: 10.1351\/goldbook.","DOI":"10.1351\/goldbook"},{"issue":"5","key":"10.1016\/j.bcp.2016.10.001_b0570","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1021\/cb300007j","article-title":"Redesign of glycopeptide antibiotics: back to the future","volume":"7","author":"James","year":"2012","journal-title":"ACS Chem. Biol."},{"issue":"10","key":"10.1016\/j.bcp.2016.10.001_b0575","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/molbev\/msi193","article-title":"Evolutionary implications of bacterial polyketide synthases","volume":"22","author":"Jenke-Kodama","year":"2005","journal-title":"Mol. Biol. Evol."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0580","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.diagmicrobio.2009.03.001","article-title":"ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591g-positive clinical isolates in 23 countries","volume":"64","author":"Jones","year":"2009","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bcp.2016.10.001_b0585","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1128\/AEM.02206-08","article-title":"Tetracycline resistome of the organic pig gut","volume":"75","author":"Kazimierczak","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.bcp.2016.10.001_b0590","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev.biochem.68.1.219","article-title":"Tolerance and specificity of polyketide synthases","volume":"68","author":"Khosla","year":"1999","journal-title":"Annu. Rev. Biochem."},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0595","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/pro.2889","article-title":"One ring to rule them all: current trends in combating bacterial resistance to the \u03b2-lactams","volume":"25","author":"King","year":"2016","journal-title":"Protein Sci."},{"issue":"3","key":"10.1016\/j.bcp.2016.10.001_b0600","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/jhmas\/jrh091","article-title":"Streptomycin, Schatz v. Waksman, and the balance of credit for discovery","volume":"59","author":"Kingston","year":"2004","journal-title":"J. Hist. Med. Allied Sci."},{"key":"10.1016\/j.bcp.2016.10.001_b0605","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.bmc.2008.10.082","article-title":"The methymycin\/pikromycin biosynthetic pathway: a model for metabolic diversity in natural product","volume":"17","author":"Kittendorf","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2016.10.001_b0610","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1016\/j.clinthera.2015.11.007","article-title":"Beyond vancomycin: the tail of the lipoglycopeptides","volume":"37","author":"Klinker","year":"2015","journal-title":"Clin. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2016.10.001_b0615","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3201\/eid1903.120246","article-title":"Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa","volume":"9","author":"Klopper","year":"2013","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.bcp.2016.10.001_b0620","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrd1657","article-title":"The evolving role of natural products in drug discovery","volume":"4","author":"Koehn","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0625","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1039\/b613652b","article-title":"Macrocyclization strategies in polyketide and nonribosomal peptide biosynthesis","volume":"24","author":"Kopp","year":"2007","journal-title":"Nat. Prod. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2016.10.001_b0630","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nchembio884","article-title":"Diarylquinolines target subunit c of mycobacterial ATP synthase","volume":"3","author":"Koul","year":"2007","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2016.10.001_b0635","doi-asserted-by":"publisher","first-page":"a027029","DOI":"10.1101\/cshperspect.a027029","article-title":"Aminoglycosides: an overview","volume":"6","author":"Krause","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bcp.2016.10.001_b0640","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13756-015-0050-y","article-title":"Antimicrobial use in Chinese swine and broiler poultry production","volume":"4","author":"Krishnasamy","year":"2015","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.bcp.2016.10.001_b0645","first-page":"632","article-title":"Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis","volume":"25","author":"Kudoh","year":"1987","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"10.1016\/j.bcp.2016.10.001_b0650","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0655","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/MAO.0000000000000937","article-title":"Frequency and demographics of gentamicin use","volume":"37","author":"Kushner","year":"2016","journal-title":"Otol. Neurotol."},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b0660","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/003335491212700103","article-title":"A review of antibiotic use in food animals: perspective, policy, and potential","volume":"127","author":"Landers","year":"2012","journal-title":"Public Health Rep."},{"issue":"6874","key":"10.1016\/j.bcp.2016.10.001_b0665","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/415835a","article-title":"Rank injustice","volume":"415","author":"Lawrence","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b0670","first-page":"29","article-title":"Two new genera of nocardioform actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov","volume":"36","author":"Lechevalier","year":"1986","journal-title":"Int. J. Syst. Evol. Microbiol."},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0675","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1086\/324626","article-title":"Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications","volume":"34","author":"Leclercq","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bcp.2016.10.001_b0680","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1741-7015-12-96","article-title":"Outpatient antibiotic prescribing in the United States: 2000 to 2010","volume":"12","author":"Lee","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.bcp.2016.10.001_b0685","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"Levine","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.bcp.2016.10.001_b0690","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1128\/AAC.00860-10","article-title":"Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis","volume":"54","author":"Llano-Sotelo","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b0695","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/jbmr.1818","article-title":"Double and quadruple tetracycline labelling of bone: impact of the label itself","volume":"28","author":"Lindsay","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0700","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study","volume":"16","author":"Liu","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.bcp.2016.10.001_b0705","first-page":"ii9","article-title":"Linezolid in vitro: mechanism and antibacterial spectrum","volume":"51","author":"Livermore","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b0710","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/anie.200461471","article-title":"The composition of Ehrlich\u2019s salvarsan: resolution of a century-old debate","volume":"44","author":"Lloyd","year":"2005","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"9859","key":"10.1016\/j.bcp.2016.10.001_b0715","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2016.10.001_b0720","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1471-2180-12-196","article-title":"Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm","volume":"12","author":"Lutz","year":"2012","journal-title":"BMC Microbiol."},{"issue":"20","key":"10.1016\/j.bcp.2016.10.001_b0725","first-page":"1056","article-title":"Lincomycin: a new antibiotic active against staphylococci and other gram-positive cocci","volume":"91","author":"MacLeod","year":"1964","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.bcp.2016.10.001_b0730","first-page":"301","article-title":"Expression and isolation of antimicrobial small molecules from soil DNA libraries","volume":"3","author":"MacNeil","year":"2001","journal-title":"J. Mol. Microbiol. Biotechnol."},{"key":"10.1016\/j.bcp.2016.10.001_b0735","doi-asserted-by":"publisher","first-page":"15997","DOI":"10.1073\/pnas.0606129103","article-title":"Ultrashort antibacterial and antifungal lipopeptides","volume":"103","author":"Makovitzki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"10.1016\/j.bcp.2016.10.001_b0740","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2105\/AJPH.33.12.1387","article-title":"Penicillin treatment of early syphilis: a preliminary report","volume":"33","author":"Mahoney","year":"1943","journal-title":"Am. J. Public Health Nations Health"},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0745","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/BF02089930","article-title":"Rifomycin. XI. Taxonomic study on Streptomyces mediterranei nov. sp.","volume":"13","author":"Margalith","year":"1960","journal-title":"Mycopathol. Mycol. Appl."},{"key":"10.1016\/j.bcp.2016.10.001_b0750","article-title":"Amikacin in critically ill patients: a review of population pharmacokinetic studies","author":"Marsot","year":"2016","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0755","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1708-8305.2009.00385.x","article-title":"Prevention of travelers\u2019 diarrhea with rifaximin in US travelers to Mexico","volume":"17","author":"Martinez-Sandoval","year":"2010","journal-title":"J. Travel Med."},{"key":"10.1016\/j.bcp.2016.10.001_b0760","unstructured":"C.V. Maxwell, D.S. Buchanan, W.G. Luce, D. McLaren, R. Vend, Direct Comparisons of Antibiotics for Growing-Finishing Swine. Animal Science Research Report, Oklahoma Agricultural Experiment Station, 235-240, 1981. Available at: http:\/\/beefextension.com\/research_reports\/research_56_94\/rr82\/rr82_55.pdf."},{"issue":"6","key":"10.1016\/j.bcp.2016.10.001_b0765","first-page":"281","article-title":"Ilotycin, a new antibiotic","volume":"2","author":"McGuire","year":"1952","journal-title":"Antibiot. Chemother. (Northfield)"},{"issue":"20","key":"10.1016\/j.bcp.2016.10.001_b0770","article-title":"First tuberculosis cases in Italy resistant to all tested drugs","volume":"12","author":"Migliori","year":"2007","journal-title":"Euro. Surveill."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0775","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7326\/0003-4819-138-2-200301210-00015","article-title":"Linezolid: the first oxazolidinone antimicrobial","volume":"138","author":"Moellering","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"18","key":"10.1016\/j.bcp.2016.10.001_b0780","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2146\/ajhp050464.p1","article-title":"Echinocandins in the management of invasive fungal infections, part 1","volume":"63","author":"Morris","year":"2006","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0785","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.chembiol.2004.12.009","article-title":"Chimeric streptogramin-tyrocidine antibiotics that overcome streptogramin resistance","volume":"12","author":"Mukhtar","year":"2005","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b0790","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2710.1995.tb00619.x","article-title":"Teicoplanin or vancomycin in the treatment of gram-positive infections?","volume":"20","author":"Murphy","year":"1995","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.bcp.2016.10.001_b0795","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/ja.2007.10","article-title":"Azalides from azithromycin to new azalide derivatives","volume":"60","author":"Mutak","year":"2007","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bcp.2016.10.001_b0800","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000195915","article-title":"Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis","volume":"58","author":"Nagai","year":"1991","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.bcp.2016.10.001_b0805","doi-asserted-by":"publisher","first-page":"e00021 13","DOI":"10.1128\/mBio.00021-13","article-title":"Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii","volume":"4","author":"Napier","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.bcp.2016.10.001_b0810","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/ajpa.21340","article-title":"Brief communication: mass spectroscopic characterization of tetracycline in the skeletal remains of an ancient population from Sudanese Nubia 350\u2013550 CE","volume":"143","author":"Nelson","year":"2010","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.bcp.2016.10.001_b0815","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1749-6632.2011.06354.x","article-title":"The history of the tetracyclines","volume":"1241","author":"Nelson","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bcp.2016.10.001_b0820","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1473-3099(05)70086-4","article-title":"Lack of development of new antimicrobial drugs: a potential serious threat to public health","volume":"5","author":"Norrby","year":"2005","journal-title":"Lancet Infect Dis."},{"issue":"39","key":"10.1016\/j.bcp.2016.10.001_b0825","doi-asserted-by":"publisher","first-page":"13522","DOI":"10.1021\/ja507009a","article-title":"Total synthesis of [\u03a8[C(NH)NH]Tpg(4)]vancomycin and its (4-chlorobiphenyl)methyl derivative: impact of peripheral modifications on vancomycin analogues redesigned for dual D-Ala-D-Ala and D-Ala-D-Lac binding","volume":"136","author":"Okano","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.bcp.2016.10.001_b0830","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1021\/jacs.5b01008","volume":"137","author":"Okano","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bcp.2016.10.001_b0835","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nbt1297","article-title":"Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338","volume":"25","author":"Oliynyk","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcp.2016.10.001_b0840","unstructured":"J. O\u2019Neill (Chair), The Review on Antimicrobial Resistance, 2014. Available at: http:\/\/amr-review.org\/sites\/default\/files\/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf."},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b0845","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/phar.1484","article-title":"Colistin: understanding and applying recent pharmacokinetic advances","volume":"35","author":"Ortwine","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.bcp.2016.10.001_b0850","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrd.2016.155","article-title":"Accelerating global innovation to address antibacterial resistance: introducing CARB-X","volume":"15","author":"Outterson","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2016.10.001_b0855","unstructured":"J. Parascandola, The history of antibiotics: a symposium. American Institute of the History of Pharmacy No. 5, 1980. ISBN 0-931292-08-5."},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0860","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7164\/antibiotics.31.276","article-title":"Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties","volume":"31","author":"Parenti","year":"1978","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"Suppl. 5","key":"10.1016\/j.bcp.2016.10.001_b0865","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/1120009X.2000.11782312","article-title":"Teicoplanin chemistry and microbiology","volume":"12","author":"Parenti","year":"2000","journal-title":"J. Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b0870","unstructured":"Pfizer, 2010. Available at: https:\/\/docs.google.com\/viewer?url=http%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2010%2F021130s022lbl.pdf."},{"key":"10.1016\/j.bcp.2016.10.001_b0875","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1128\/jcm.32.6.1542-1546.1994","article-title":"Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis","volume":"32","author":"Plikaytis","year":"1994","journal-title":"J. Clin. Microbiol."},{"issue":"17","key":"10.1016\/j.bcp.2016.10.001_b0880","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.1128\/JB.00011-12","article-title":"Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins","volume":"194","author":"Pogliano","year":"2012","journal-title":"J. Bacteriol."},{"issue":"7","key":"10.1016\/j.bcp.2016.10.001_b0885","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1080\/14740338.2016.1186639","article-title":"Rifaximin for the treatment of irritable bowel syndrome \u2013 a drug safety evaluation","volume":"15","author":"Ponziani","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.bcp.2016.10.001_b0890","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev.pharmtox.42.091601.142813","article-title":"Glycopeptide antibiotic resistance","volume":"42","author":"Pootoolal","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"25","key":"10.1016\/j.bcp.2016.10.001_b0895","doi-asserted-by":"publisher","first-page":"7906","DOI":"10.1021\/bi962785k","article-title":"Nonlamellar phases induced by the interaction of gramicidin S with lipid bilayers. A possible relationship to membrane-disrupting activity","volume":"36","author":"Prenner","year":"1997","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b0900","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/febs.12108","article-title":"Kinetic mechanism and inhibition of Mycobacterium tuberculosis d-alanine: D-alanine ligase by the antibiotic d-cycloserine","volume":"280","author":"Prosser","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2016.10.001_b0905","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/md8030498","article-title":"Novel anti-infective compounds from marine bacteria","volume":"8","author":"Rahman","year":"2010","journal-title":"Mar. Drugs"},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b0910","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1054\/tuld.1998.0002","article-title":"Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update","volume":"79","author":"Ramaswamy","year":"1998","journal-title":"Tuber. Lung Dis."},{"issue":"3","key":"10.1016\/j.bcp.2016.10.001_b0915","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1128\/AAC.00327-13","article-title":"New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver disease","volume":"58","author":"Rao","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b0920","first-page":"371","article-title":"Antibacterial activity in mice of minocycline, a new tetracycline","volume":"6","author":"Redin","year":"1966","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b0925","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"197","author":"Rice","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b0930","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1021\/ja00834a039","article-title":"Chemistry and biochemistry of the streptovaricins. XII. Atropisomeric streptovaricins","volume":"97","author":"Rinehart","year":"1975","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.bcp.2016.10.001_b0935","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/phar.1641","article-title":"Dalbavancin and oritavancin: an innovative approach to the treatment of gram-positive infections","volume":"35","author":"Roberts","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bcp.2016.10.001_b0940","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1128\/AAC.01649-07","article-title":"In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus","volume":"52","author":"Robertson","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b0945","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1476-5381.1952.tb00686.x","article-title":"Acquired resistance to penicillin and to neoarsphenamine in Spirochaeta recurrentis","volume":"7","author":"Rollo","year":"1952","journal-title":"Br. J. Pharmacol. Chemother."},{"issue":"8","key":"10.1016\/j.bcp.2016.10.001_b0950","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1592\/phco.26.8.1099","article-title":"Tigecycline: first of a new class of antimicrobial agents","volume":"26","author":"Rose","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"25","key":"10.1016\/j.bcp.2016.10.001_b0955","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1021\/bi00827a002","article-title":"Tyrocidine biosynthesis by three complementary fractions from Bacillus brevis (ATCC 8185)","volume":"9","author":"Roskoski","year":"1970","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2016.10.001_b0960","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bcp.2016.10.001_b0965","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ardp.200700080","article-title":"Rifalazil and other benzoxazinorifamycins in the treatment of chlamydia-based persistent infections","volume":"340","author":"Rothstein","year":"2007","journal-title":"Arch. Pharm. (Weinheim)"},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2016.10.001_b0970","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1469-0691.2006.01342.x","article-title":"The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria","volume":"12","author":"Rybak","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2016.10.001_b0975","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/apt.13436","article-title":"Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases","volume":"43","author":"Sartor","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2016.10.001_b0980","first-page":"409","article-title":"Telithromycin: a brief review of a new ketolide antibiotic","volume":"3","author":"Scheinfeld","year":"2004","journal-title":"J. Drug Dermatol."},{"issue":"5","key":"10.1016\/j.bcp.2016.10.001_b0985","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.femsre.2004.04.001","article-title":"Molecular basis of bacterial resistance to chloramphenicol and florfenicol","volume":"28","author":"Schwarz","year":"2004","journal-title":"FEMS Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b0990","first-page":"118","article-title":"Modern medicine and the twentieth century decline in mortality: evidence on the impact of sulfa drugs","volume":"2","author":"Seema","year":"2010","journal-title":"Am. Econ. J.: Appl. Econ."},{"key":"10.1016\/j.bcp.2016.10.001_b0995","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Suppl. 3","key":"10.1016\/j.bcp.2016.10.001_b1000","doi-asserted-by":"publisher","first-page":"S402","DOI":"10.1093\/clinids\/5.Supplement_3.S402","article-title":"History of the development of rifampin","volume":"5","author":"Sensi","year":"1983","journal-title":"Rev. Infect. Dis."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b1005","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1128\/CMR.8.2.180","article-title":"Tuberculosis in the AIDS era","volume":"8","author":"Sepkowitz","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b1010","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/jac\/dkt301","article-title":"Antibiotic prescribing for adults in ambulatory care in the USA, 2007\u201309","volume":"69","author":"Shapiro","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b1015","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.brainresrev.2004.04.004","article-title":"Molecular pharmacology of glutamate transporters, EAATs and VGLUTs","volume":"45","author":"Shigeri","year":"2004","journal-title":"Brain Res. Rev."},{"issue":"8","key":"10.1016\/j.bcp.2016.10.001_b1020","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1517\/13543784.8.8.1195","article-title":"Mechanism of action of the oxazolidinone antibacterial agents","volume":"8","author":"Shinabarger","year":"1999","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bcp.2016.10.001_b1025","series-title":"The Killers Within: The Deadly Rise of Drug-Resistant Bacteria","author":"Shnayerson","year":"2003"},{"issue":"11","key":"10.1016\/j.bcp.2016.10.001_b1030","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1128\/AAC.31.11.1791","article-title":"Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721","volume":"31","author":"Slee","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"issue":"21","key":"10.1016\/j.bcp.2016.10.001_b1035","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJM200511243532123","article-title":"Mitochondrial toxicity associated with linezolid","volume":"353","author":"Soriano","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.bcp.2016.10.001_b1040","doi-asserted-by":"publisher","first-page":"7102","DOI":"10.1073\/pnas.1402358111","article-title":"A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteria","volume":"111","author":"Spanogiannopoulos","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b1045","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1128\/jb.173.1.176-183.1991","article-title":"Evidence that a novel tetracycline resistance gene found on two Bacteroides transposons encodes an NADP-requiring oxidoreductase","volume":"173","author":"Speer","year":"1991","journal-title":"J. Bacteriol."},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b1050","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2165\/00019053-199507040-00009","article-title":"Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections","volume":"7","author":"Spencer","year":"1995","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.bcp.2016.10.001_b1055","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1021\/ja01613a107","article-title":"Synthesis of D-4-amino-3-isoxazolidinone","volume":"77","author":"Stammer","year":"1955","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.bcp.2016.10.001_b1060","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/jac\/dkh546","article-title":"Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections","volume":"55","author":"Steenbergen","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b1065","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrd2582","article-title":"Paul Ehrlich: founder of chemotherapy","volume":"7","author":"Kaufmann","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b1070","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1756-3305-3-15","article-title":"The development of drugs for treatment of sleeping sickness: a historical review","volume":"3","author":"Steverding","year":"2010","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.bcp.2016.10.001_b1075","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1146\/annurev.bi.46.070177.003451","article-title":"Polymyxin and related peptide antibiotics","volume":"46","author":"Storm","year":"1977","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bcp.2016.10.001_b1080","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1016\/j.bmc.2012.08.007","article-title":"Synthesis and structure-activity relationship of a novel class of 15-membered macrolide antibiotics known as \u201811a-azalides\u2019","volume":"20","author":"Sugimoto","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2016.10.001_b1085","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1086\/499819","article-title":"Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America","volume":"42","author":"Talbot","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b1090","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/jac\/46.4.523","article-title":"Development of daptomycin for gram-positive infections","volume":"46","author":"Tally","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.bcp.2016.10.001_b1095","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0022-2836(03)00662-4","article-title":"The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome","volume":"330","author":"Tenson","year":"2003","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b1100","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/BF00409680","article-title":"A proposal for the transfer of Streptomyces mediterranei Margalith and Beretta 1960 to the genus Nocardia as Nocardia mediterranea (Margalith and Beretta) comb. nov","volume":"67","author":"Thiemann","year":"1969","journal-title":"Arch. Mikrobiol."},{"issue":"6","key":"10.1016\/j.bcp.2016.10.001_b1105","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/jac\/dkg254","article-title":"Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review","volume":"51","author":"Thomas","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b1110","doi-asserted-by":"publisher","first-page":"5638","DOI":"10.1073\/pnas.082092899","article-title":"Mechanism of plasmid-mediated quinolone resistance","volume":"99","author":"Tran","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.10.001_b1115","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1128\/AAC.49.1.118-125.2005","article-title":"Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase","volume":"49","author":"Tran","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b1120","first-page":"756","article-title":"Activit\u00e9 du p-aminoph\u00e9nylsulfamide sur l\u2019infection streptococcique exp\u00e9rimentale de la souris et du lapin","volume":"120","author":"Tr\u00e9fou\u00ebl","year":"1935","journal-title":"C. R. Soc. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2016.10.001_b1125","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ijantimicag.2009.12.017","article-title":"Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns","volume":"35","author":"Tupin","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bcp.2016.10.001_b1130","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/cid\/cir889","article-title":"Totally drug-resistant tuberculosis in India","volume":"54","author":"Udwadia","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.bcp.2016.10.001_b1135","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1073\/pnas.68.3.672","article-title":"The gramicidin A transmembrane channel: a proposed pi(L, D) helix","volume":"68","author":"Urry","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.bcp.2016.10.001_b1140","first-page":"740","article-title":"Glycopeptides and glycodepsipeptides in clinical development: a comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacy","volume":"7","author":"Van Bambeke","year":"2006","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"8","key":"10.1016\/j.bcp.2016.10.001_b1145","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"18","key":"10.1016\/j.bcp.2016.10.001_b1150","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1073\/pnas.1503141112","article-title":"Global trends in antimicrobial use in food animals","volume":"112","author":"Van Boeckel","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2016.10.001_b1155","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1378\/chest.08-2427","article-title":"Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis of totally drug-resistant strain in Iran","volume":"136","author":"Velayati","year":"2009","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.bcp.2016.10.001_b1160","first-page":"307","article-title":"The totally drug resistant tuberculosis (TDR-TB)","volume":"6","author":"Velayati","year":"2013","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b1165","first-page":"97","article-title":"Streptomycin: discovery and resultant controversy","volume":"13","author":"Wainwright","year":"1991","journal-title":"Hist. Philos. Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b1170","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/jhmas\/jri024","article-title":"Response to William Kingston, \u201cStreptomycin, Schatz versus Waksman, and the balance of credit for discovery\u201d","volume":"60","author":"Wainwright","year":"2005","journal-title":"J. Hist. Med. Allied Sci."},{"key":"10.1016\/j.bcp.2016.10.001_b1175","series-title":"The Conquest of Tuberculosis","first-page":"241","author":"Waksman","year":"1964"},{"issue":"3","key":"10.1016\/j.bcp.2016.10.001_b1180","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1128\/br.35.3.290-309.1971","article-title":"Actions of the rifamycins","volume":"35","author":"Wehrli","year":"1971","journal-title":"Bacteriol. Rev."},{"key":"10.1016\/j.bcp.2016.10.001_b1185","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1128\/AAC.39.3.577","article-title":"Erythromycin resistance by ribosome modification","volume":"39","author":"Weisblum","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b1190","series-title":"Quinolone Antimicrobial Agents","first-page":"XIII","article-title":"In memoriam: George Y. Lesher, Ph.D.","author":"Wentland","year":"1993"},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b1195","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/jac\/37.2.209","article-title":"The comparative efficacy and safety of teicoplanin and vancomycin","volume":"37","author":"Wood","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bcp.2016.10.001_b1200","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-3-642-28951-4_2","article-title":"The origins of antibiotic resistance","volume":"211","author":"Wright","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2016.10.001_b1205","first-page":"195","article-title":"The clinical value of aureomycin: a review of current literature and some unpublished data","volume":"41","author":"Wright","year":"1949","journal-title":"J. Natl Med. Assoc."},{"issue":"3","key":"10.1016\/j.bcp.2016.10.001_b1210","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4065\/74.3.290","article-title":"The penicillins","volume":"74","author":"Wright","year":"1999","journal-title":"Mayo Clin. Proc."},{"issue":"35","key":"10.1016\/j.bcp.2016.10.001_b1215","doi-asserted-by":"publisher","first-page":"13946","DOI":"10.1021\/ja207142h","article-title":"A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria","volume":"133","author":"Xie","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b1220","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1021\/ja209937s","article-title":"Total synthesis of [\u03a8[C(S)NH]Tpg4]vancomycin aglycon, [\u03a8[C(NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding","volume":"134","author":"Xie","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.bcp.2016.10.001_b1225","first-page":"1","article-title":"Deaths: final data for 2013","volume":"64","author":"Xu","year":"2016","journal-title":"Natl. Vital Stat. Rep."},{"key":"10.1016\/j.bcp.2016.10.001_b1230","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/194183b0","article-title":"Virginiamycin as an antibiotic for poultry feeds","volume":"194","author":"Yates","year":"1962","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bcp.2016.10.001_b1235","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2165\/11534440-000000000-00000","article-title":"New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin","volume":"70","author":"Zhanel","year":"2010","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.bcp.2016.10.001_b1240","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijantimicag.2016.04.017","article-title":"Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance","volume":"48","author":"Pournaras","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"9","key":"10.1016\/j.bcp.2016.10.001_b1245","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria","volume":"33","author":"Evans","year":"1999","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.bcp.2016.10.001_b1250","unstructured":"WHO, Guidelines of the Programmatic Management of Drug-Resistant Tuberculosis, 2006. Available at: http:\/\/whqlibdoc.who.int\/publications\/2006\/9241546956_eng.pdf."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216303318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295216303318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T07:19:27Z","timestamp":1692515967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295216303318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":250,"alternative-id":["S0006295216303318"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2016.10.001","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"History of antimicrobial drug discovery: Major classes and health impact","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2016.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}